Youcef Mehellou
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
Papers in
-
- Biochemical and Molecular Research 10
- Ion Transport and Channel Regulation 8
- Protein Kinase Regulation and GTPase Signaling 7
- Metabolism, Diabetes, and Cancer 3
- Signaling Pathways in Disease 3
-
- HIV/AIDS drug development and treatment 11
- Co-authors
- Erik De Clercq (1 shared paper)Jan Balzarini (3 shared papers)Christopher McGuigan (5 shared papers)Hachemi Kadri (12 shared papers)Dario R. Alessi (4 shared papers)Mária Deák (2 shared papers)Thomas Macartney (2 shared papers)Thimo Kurz (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (9 papers)ChemMedChem (8 papers)ChemBioChem (6 papers)Biochemical and Biophysical Research Communications (4 papers)Biochemical Journal (2 papers)
- Partner nations
- United KingdomBelgiumUnited States
In The Last Decade
Youcef Mehellou
40 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 101
- Virology 225
- Infectious Diseases 567
- Organic Chemistry 485
- Molecular Biology 1.1k
- Physiology 54
Countries citing papers authored by Youcef Mehellou
This map shows the geographic impact of Youcef Mehellou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youcef Mehellou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youcef Mehellou more than expected).
Fields of papers citing papers by Youcef Mehellou
This network shows the impact of papers produced by Youcef Mehellou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youcef Mehellou. The network helps show where Youcef Mehellou may publish in the future.
Co-authors
The 25 scholars most cited alongside Youcef Mehellou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 311 | |
| 2 | 2017 | 245 | |
| 3 | 2009 | 182 | |
| 4 | 2013 | 173 | |
| 5 | 2011 | 112 | |
| 6 | 2011 | 105 | |
| 7 | 2016 | 88 | |
| 8 | 2018 | 81 | |
| 9 | 2017 | 72 | |
| 10 | 2017 | 50 | |
| 11 | 2017 | 46 | |
| 12 | 2014 | 41 | |
| 13 | 2017 | 37 | |
| 14 | 2016 | 36 | |
| 15 | 2010 | 30 | |
| 16 | 2016 | 30 | |
| 17 | 2009 | 28 | |
| 18 | 2018 | 27 | |
| 19 | 2007 | 25 | |
| 20 | 2013 | 20 |
About Youcef Mehellou
Youcef Mehellou is a scholar working on Molecular Biology, Infectious Diseases, Organic Chemistry, Epidemiology and Oncology, having authored 40 papers that have together received 1.9k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (11 papers), Biochemical and Molecular Research (10 papers), Ion Transport and Channel Regulation (8 papers), Protein Kinase Regulation and GTPase Signaling (7 papers), Parkinson's Disease Mechanisms and Treatments (5 papers), HIV Research and Treatment (4 papers), Metabolism, Diabetes, and Cancer (3 papers) and Signaling Pathways in Disease (3 papers). The work is most often cited by research in Virology (225 citations), Infectious Diseases (567 citations), Organic Chemistry (485 citations), Molecular Biology (1.1k citations) and Physiology (54 citations). Youcef Mehellou has collaborated with scholars based in United Kingdom, Belgium and United States. Frequent co-authors include Erik De Clercq, Jan Balzarini, Christopher McGuigan, Hachemi Kadri, Jan Balzarini, Dario R. Alessi, Mária Deák, Thomas Macartney, Thimo Kurz and Frances‐Rose Schumacher. Their work appears in journals such as Journal of Medicinal Chemistry, ChemMedChem, ChemBioChem, Biochemical and Biophysical Research Communications and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.